New research reveals 25% tariffs on Canadian pharmaceuticals would impact critical medications, strain supply chains, and potentially increase costs—with 28 drugs having no alternative suppliers.
Individuals with autoimmune arthritides are more likely to experience mood and anxiety disorders—even relative to counterparts with other chronic illnesses—according to a national cohort study.
A study finds that total hip arthroplasty in patients with minimal radiographic osteoarthritis results in high satisfaction but lower functional outcomes, with only 33% achieving a patient-acceptable symptom state.
Proposals include licensure for community health workers, expanded provider roles, and Medicaid coverage adjustments to address staffing gaps and access barriers.
KFF Health News
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
The FDA has approved guselkumab (TREMFYA®) for moderately to severely active Crohn’s disease, supported by Phase 3 trial data showing clinical and endoscopic superiority over ustekinumab.
Patients with gout initiating urate-lowering therapy had a reduced risk of cardiovascular events when prescribed colchicine prophylaxis, researchers report.